Martijn C de Wilde - Related publications

Affiliations: 
RB 
Area:
Neuroscience, neurodgenerative, nutrition
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
23 most relevant papers in past 60 days:
Year Citation  Score
2021 Montine TJ, Bukhari SA, White LR. Cognitive Impairment in Older Adults and Therapeutic Strategies. Pharmacological Reviews. 73: 152-162. PMID 33298513 DOI: 10.1124/pharmrev.120.000031   
2021 Yang M, Yang Z, Wang P, Sun Z. Current application and future directions of photobiomodulation in central nervous diseases. Neural Regeneration Research. 16: 1177-1185. PMID 33269767 DOI: 10.4103/1673-5374.300486   
2021 Yoo J, Park HH, Yun IS, Hong CK. Clinical applications of the endoscopic transorbital approach for various lesions. Acta Neurochirurgica. PMID 33394139 DOI: 10.1007/s00701-020-04694-y   
2021 Zhang X, Liu J, Chen Y, Jin Y, Cheng J, . Brain network construction and analysis for patients with mild cognitive impairment and Alzheimer's disease based on a highly-available nodes approach. Brain and Behavior. e02027. PMID 33393200 DOI: 10.1002/brb3.2027   
2021 Papp KV, Rentz DM, Maruff P, Sun CK, Raman R, Donohue MC, Schembri A, Stark C, Yassa MA, Wessels AM, Yaari R, Holdridge KC, Aisen PS, Sperling RA. The Computerized Cognitive Composite (C3) in an Alzheimer's Disease Secondary Prevention Trial. The Journal of Prevention of Alzheimer's Disease. 8: 59-67. PMID 33336226 DOI: 10.14283/jpad.2020.38   
2021 Jagust WJ, Landau SM, . Temporal Dynamics of Beta-amyloid Accumulation in Aging and Alzheimer's Disease. Neurology. PMID 33408147 DOI: 10.1212/WNL.0000000000011524   
2021 Stojakovic A, Trushin S, Sheu A, Khalili L, Chang SY, Li X, Christensen T, Salisbury JL, Geroux RE, Gateno B, Flannery PJ, Dehankar M, Funk CC, Wilkins J, Stepanova A, et al. Partial inhibition of mitochondrial complex I ameliorates Alzheimer's disease pathology and cognition in APP/PS1 female mice. Communications Biology. 4: 61. PMID 33420340 DOI: 10.1038/s42003-020-01584-y   
2021 Lane HY, Tu CH, Lin WC, Lin CH. Brain activity of benzoate, a D-amino acid oxidase inhibitor, in patients with mild cognitive impairment in a randomized, double-blind, placebo controlled clinical trial. The International Journal of Neuropsychopharmacology. PMID 33406269 DOI: 10.1093/ijnp/pyab001   
2021 O'Dell RS, Mecca AP, Chen MK, Naganawa M, Toyonaga T, Lu Y, Godek TA, Harris JE, Bartlett HH, Banks ER, Kominek VL, Zhao W, Nabulsi NB, Ropchan J, Ye Y, et al. Association of Aβ deposition and regional synaptic density in early Alzheimer's disease: a PET imaging study with [C]UCB-J. Alzheimer's Research & Therapy. 13: 11. PMID 33402201 DOI: 10.1186/s13195-020-00742-y   
2021 Dai L, Zou L, Meng L, Qiang G, Yan M, Zhang Z. Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets. Molecular Neurobiology. PMID 33411241 DOI: 10.1007/s12035-020-02232-6   
2021 Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches. The Lancet. Neurology. 20: 68-80. PMID 33340485 DOI: 10.1016/S1474-4422(20)30412-9   
2021 Chatterjee M, Kwon J, Benedict J, Kamceva M, Kurup P, Lombroso PJ. STEP inhibition prevents Aβ-mediated damage in dendritic complexity and spine density in Alzheimer's disease. Experimental Brain Research. PMID 33420799 DOI: 10.1007/s00221-020-06028-x   
2021 Fontana L, Ghezzi L, Cross AH, Piccio L. Effects of dietary restriction on neuroinflammation in neurodegenerative diseases. The Journal of Experimental Medicine. 218. PMID 33416892 DOI: 10.1084/jem.20190086   
2021 Talebi M, İlgün S, Ebrahimi V, Talebi M, Farkhondeh T, Ebrahimi H, Samarghandian S. Zingiber officinale ameliorates Alzheimer's disease and Cognitive Impairments: Lessons from preclinical studies. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 133: 111088. PMID 33378982 DOI: 10.1016/j.biopha.2020.111088   
2021 Syeda T, Cannon JR. Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target. Journal of Biochemical and Molecular Toxicology. e22694. PMID 33393683 DOI: 10.1002/jbt.22694   
2021 Cox CG, Ryan MM, Gillen DL, Grill JD. Is Reluctance to Share Alzheimer's Disease Biomarker Status with a Study Partner a Barrier to Preclinical Trial Recruitment? The Journal of Prevention of Alzheimer's Disease. 8: 52-58. PMID 33336225 DOI: 10.14283/jpad.2020.36   
2021 Wani A, Al Rihani SB, Sharma A, Weadick B, Govindarajan R, Khan SU, Sharma PR, Dogra A, Nandi U, Reddy CN, Bharate SS, Singh G, Bharate SB, Vishwakarma RA, Kaddoumi A, et al. Crocetin promotes clearance of amyloid-β by inducing autophagy via the STK11/LKB1-mediated AMPK pathway. Autophagy. PMID 33404280 DOI: 10.1080/15548627.2021.1872187   
2021 Pelkmans W, Legdeur N, Ten Kate M, Barkhof F, Yaqub MM, Holstege H, van Berckel BNM, Scheltens P, van der Flier WM, Visser PJ, Tijms BM. Amyloid-β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest-old. Annals of Clinical and Translational Neurology. PMID 33421355 DOI: 10.1002/acn3.51273   
2021 Zammit MD, Tudorascu DL, Laymon CM, Hartley SL, Zaman SH, Ances BM, Johnson SC, Stone CK, Mathis CA, Klunk WE, Cohen AD, Handen BL, Christian BT. PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndrome. Neuroimage. 117728. PMID 33421595 DOI: 10.1016/j.neuroimage.2021.117728   
2021 Pons V, Lévesque P, Plante MM, Rivest S. Conditional genetic deletion of CSF1 receptor in microglia ameliorates the physiopathology of Alzheimer's disease. Alzheimer's Research & Therapy. 13: 8. PMID 33402196 DOI: 10.1186/s13195-020-00747-7   
2021 Ng KP, Pascoal TA, Mathotaarachchi S, Chan YH, Jiang L, Therriault J, Benedet AL, Shin M, Kandiah N, Greenwood CMT, Rosa-Neto P, Gauthier S, . Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease. Translational Neurodegeneration. 10: 1. PMID 33390174 DOI: 10.1186/s40035-020-00225-y   
2021 Shin SJ, Nam Y, Park YH, Kim MJ, Lee E, Jeon SG, Bae BS, Seo J, Shim SL, Kim JS, Han CK, Kim S, Lee YY, Moon M. Therapeutic effects of non-saponin fraction with rich polysaccharide from Korean red ginseng on aging and Alzheimer's disease. Free Radical Biology & Medicine. PMID 33422674 DOI: 10.1016/j.freeradbiomed.2020.12.454   
2021 Ruiz-Gómez SJ, Hornero R, Poza J, Santamaría-Vázquez E, Rodríguez-González V, Maturana-Candelas A, Gomez C. A new method to build multiplex networks using Canonical Correlation Analysis for the characterization of the Alzheimer's disease continuum. Journal of Neural Engineering. PMID 33395667 DOI: 10.1088/1741-2552/abd82c